Anders Sjostedt
Overview
Explore the profile of Anders Sjostedt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
127
Citations
4632
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lindgren H, Liu X, Sjostedt A
Front Cell Infect Microbiol
. 2024 Apr;
14:1381776.
PMID: 38628552
Introduction: For a majority of tularemia patients, serology is the basis for the diagnosis. The aim of this study was to perform an analysis of the samples analyzed at a...
2.
Plymoth M, Lundqvist R, Nystedt A, Sjostedt A, Gustafsson T
Clin Infect Dis
. 2024 Feb;
78(5):1222-1231.
PMID: 38393822
Background: Tularemia is an important reemerging disease with a multimodal transmission pattern. Treatment outcomes of current recommended antibiotic regimens (including ciprofloxacin and doxycycline) remain unclear. In this retrospective cohort study,...
3.
Nelson C, Sjostedt A
Clin Infect Dis
. 2024 Jan;
78(Suppl 1):S1-S3.
PMID: 38294109
No abstract available.
4.
Lindgren H, Eneslatt K, Golovliov I, Gelhaus C, Sjostedt A
Front Immunol
. 2023 Oct;
14:1238391.
PMID: 37781364
is the etiological agent of the potentially severe infection tularemia. An existing vaccine, the live vaccine strain (LVS), has been used to protect at-risk personnel, but it is not licensed...
5.
Liu X, Tabibzada N, Lindgren H, Sjostedt A
Front Cell Infect Microbiol
. 2023 Jul;
13:1192038.
PMID: 37465761
Interpretation of serological findings in suspected Lyme borreliosis (LB) is challenging and IgM reactivities may have low predictive value. Therefore, if used indiscriminately, there is a risk for incorrect diagnosis...
6.
Lindgren H, Eklund J, Eneslatt K, Sjostedt A
Front Cell Infect Microbiol
. 2023 Jan;
12:1072703.
PMID: 36683705
Serological analysis is the predominant method used to diagnose tularemia, a zoonotic disease caused by the highly virulent bacterium . We determined -specific IgM and IgG antibody titers by an...
7.
De Pascalis R, Frey B, Rice H, Bhargava V, Wu T, Peterson R, et al.
NPJ Vaccines
. 2022 Aug;
7(1):95.
PMID: 35977964
Francisella tularensis, the causative agent of tularemia, is classified as Tier 1 Select Agent with bioterrorism potential. The efficacy of the only available vaccine, LVS, is uncertain and it is...
8.
Nadeem A, Berg A, Pace H, Alam A, Toh E, Aden J, et al.
Elife
. 2022 Feb;
11.
PMID: 35131030
The α-pore-forming toxins (α-PFTs) from pathogenic bacteria damage host cell membranes by pore formation. We demonstrate a remarkable, hitherto unknown mechanism by an α-PFT protein from . As part of...
9.
Ozanic M, Marecic V, Knezevic M, Kelava I, Stojkova P, Lindgren L, et al.
PLoS One
. 2022 Jan;
17(1):e0261938.
PMID: 35077486
Francisella tularensis is a highly pathogenic intracellular bacterium that causes the disease tularemia. While its ability to replicate within cells has been studied in much detail, the bacterium also encodes...
10.
Mohammadi N, Lindgren H, Yamamoto M, Martin A, Henry T, Sjostedt A
Front Cell Infect Microbiol
. 2022 Jan;
11:784101.
PMID: 35004352
is a facultative intracellular bacterium and the etiological agent of tularemia, a zoonotic disease. Infection of monocytic cells by can be controlled after activation with IFN-γ; however, the molecular mechanisms...